185 related articles for article (PubMed ID: 29277475)
1. Subtractive genome analysis for in silico identification and characterization of novel drug targets in Streptococcus pneumonia strain JJA.
Wadood A; Jamal A; Riaz M; Khan A; Uddin R; Jelani M; Azam SS
Microb Pathog; 2018 Feb; 115():194-198. PubMed ID: 29277475
[TBL] [Abstract][Full Text] [Related]
2. Computational screening of potential drug targets for pathogens causing bacterial pneumonia.
Nayak S; Pradhan D; Singh H; Reddy MS
Microb Pathog; 2019 May; 130():271-282. PubMed ID: 30914386
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal infection in children: rational antibiotic choice for drug-resistant Streptococcus pneumoniae.
Chiou CC; Hseih KS
Acta Paediatr Taiwan; 2003; 44(2):67-74. PubMed ID: 12845845
[TBL] [Abstract][Full Text] [Related]
4. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
Uddin R; Sufian M
PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
[TBL] [Abstract][Full Text] [Related]
5.
Duguma T; Dinka H
Biomed Res Int; 2024; 2024():5917667. PubMed ID: 38283072
[No Abstract] [Full Text] [Related]
6. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
Lynch JP; Zhanel GG
Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783
[TBL] [Abstract][Full Text] [Related]
7. The approach to treatment of invasive pneumococcal disease in the 1990s.
Knapp KM; Schutze GE
J Ark Med Soc; 1997 Nov; 94(6):263-6. PubMed ID: 9392928
[TBL] [Abstract][Full Text] [Related]
8. Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media.
Keller LE; Bradshaw JL; Pipkins H; McDaniel LS
Front Cell Infect Microbiol; 2016; 6():55. PubMed ID: 27242973
[TBL] [Abstract][Full Text] [Related]
9. [Streptococcus pneumoniae and beta-lactam antibiotic agents].
Ranin L; Vucković-Opavski N; Berger-Jekić O
Srp Arh Celok Lek; 1996; 124(1-2):18-23. PubMed ID: 9102809
[TBL] [Abstract][Full Text] [Related]
10. Low Concentrations of Nitric Oxide Modulate Streptococcus pneumoniae Biofilm Metabolism and Antibiotic Tolerance.
Allan RN; Morgan S; Brito-Mutunayagam S; Skipp P; Feelisch M; Hayes SM; Hellier W; Clarke SC; Stoodley P; Burgess A; Ismail-Koch H; Salib RJ; Webb JS; Faust SN; Hall-Stoodley L
Antimicrob Agents Chemother; 2016 Apr; 60(4):2456-66. PubMed ID: 26856845
[TBL] [Abstract][Full Text] [Related]
11. Impact of Antibiotic Resistance on Treatment of Pneumococcal Disease in Ethiopia: An Agent-Based Modeling Simulation.
Chen HH; Stringer A; Eguale T; Rao GG; Ozawa S
Am J Trop Med Hyg; 2019 Nov; 101(5):1042-1053. PubMed ID: 31516111
[TBL] [Abstract][Full Text] [Related]
12. The drug-resistant pneumococcus: clinical relevance, therapy, and prevention.
Harwell JI; Brown RB
Chest; 2000 Feb; 117(2):530-41. PubMed ID: 10669700
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal carriage of community-acquired, antibiotic-resistant Streptococcus pneumoniae in a Zambian paediatric population.
Woolfson A; Huebner R; Wasas A; Chola S; Godfrey-Faussett P; Klugman K
Bull World Health Organ; 1997; 75(5):453-62. PubMed ID: 9447779
[TBL] [Abstract][Full Text] [Related]
14. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period.
Liñares J; Ardanuy C; Pallares R; Fenoll A
Clin Microbiol Infect; 2010 May; 16(5):402-10. PubMed ID: 20132251
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of nasopharyngeal antibiotic-resistant pneumococcal carriage in children attending private paediatric practices in Johannesburg.
Huebner RE; Wasas AD; Klugman KP;
S Afr Med J; 2000 Nov; 90(11):1116-21. PubMed ID: 11196033
[TBL] [Abstract][Full Text] [Related]
16. Will reduction of antibiotic use reduce antibiotic resistance?: The pneumococcus paradigm.
Dagan R; Barkai G; Leibovitz E; Dreifuss E; Greenberg D
Pediatr Infect Dis J; 2006 Oct; 25(10):981-6. PubMed ID: 17006311
[TBL] [Abstract][Full Text] [Related]
17. [Pneumococcal antibiotic resistance].
Moreillon P; Wenger A; Caldelari I
Rev Med Suisse Romande; 2000 Aug; 120(8):651-9. PubMed ID: 11028185
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and antimicrobial resistance of Streptococcus pneumoniae in France in 2007: data from the pneumococcus surveillance network.
Kempf M; Baraduc R; Bonnabau H; Brun M; Chabanon G; Chardon H; Croizé J; Demachy MC; Donnio PY; Dupont P; Fosse T; Gibel L; Gravet A; Grignon B; Hadou T; Hamdad F; Joly-Guillou ML; Koeck JL; Maugein J; Péchinot A; Ploy MC; Raymond J; Ros A; Roussel-Delvallez M; Segonds C; Vergnaud M; Vernet-Garnier V; Lepoutre A; Gutmann L; Varon E; Lanotte P
Microb Drug Resist; 2011 Mar; 17(1):31-6. PubMed ID: 20809835
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal effect of bovine lactoferrin and synthetic peptide lactoferrin chimera in Streptococcus pneumoniae and the decrease in luxS gene expression by lactoferrin.
León-Sicairos N; Angulo-Zamudio UA; Vidal JE; López-Torres CA; Bolscher JG; Nazmi K; Reyes-Cortes R; Reyes-López M; de la Garza M; Canizalez-Román A
Biometals; 2014 Oct; 27(5):969-80. PubMed ID: 25053107
[TBL] [Abstract][Full Text] [Related]
20. [An update of Streptococcus pneumoniae: from genomic to clinic].
Wintenberger C
Med Mal Infect; 2010 Oct; 40(10):605-9. PubMed ID: 20934286
[No Abstract] [Full Text] [Related]
[Next] [New Search]
